A Comprehensive Procedure to Evaluate the <em>In Vitro</em> Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay

Ying Wang; DanQi Chen; MingYu Chen; KaiYuan Ji; DeXuan Ma; LiangFu Zhou

doi:10.3791/57183

A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangiob...

JoVE Journal
Cancer Research

A subscription to JoVE is required to view this content. Sign in or start your free trial.

JoVE Journal Cancer Research

A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay

A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay

Full Text

8,610 Views

08:26 min

April 12, 2018

DOI: 10.3791/57183-v

Ying Wang¹, DanQi Chen¹, MingYu Chen¹, KaiYuan Ji¹, DeXuan Ma¹, LiangFu Zhou¹

¹Department of Neurosurgery, Huashan Hospital,Fudan University

Overview

This study evaluates the neovascularization of hemangioblastomas (HBs) using an in vitro spheroid sprouting assay. The findings suggest that classic tumor angiogenesis is a complementary mechanism in HB-neovascularization.

Key Study Components

Area of Science

Neuroscience
Oncology
Angiogenesis

Background

Hemangioblastomas are vascular tumors associated with complex neovascularization.
Understanding angiogenesis in HBs is crucial for therapeutic advancements.
Classic tumor angiogenesis may play a role in HB development.
In vitro assays can provide insights into tumor vasculature mechanisms.

Purpose of Study

To assess the role of classic tumor angiogenesis in hemangioblastomas.
To utilize the spheroid sprouting assay for evaluating neovascularization.
To explore implications for hemangioblastoma therapy.

Methods Used

Spheroid sprouting assay to evaluate neovascularization.
In vitro techniques to assess angiogenic mechanisms.
Comparative analysis of classic angiogenesis in HBs.
Evaluation of therapeutic implications based on findings.

Main Results

Classic tumor angiogenesis exists in hemangioblastomas.
Neovascularization in HBs is complex and multifactorial.
Classic angiogenesis is a complementary mechanism in HB development.
Insights gained may inform future therapeutic strategies.

Conclusions

The study enhances understanding of hemangioblastoma neovascularization.
Classic angiogenesis contributes to but does not solely drive HB development.
Further research is needed to explore therapeutic applications.

Frequently Asked Questions

What is the significance of hemangioblastomas?

Hemangioblastomas are significant due to their vascular nature and association with conditions like von Hippel-Lindau disease.

How does the spheroid sprouting assay work?

The spheroid sprouting assay evaluates the ability of tumor cells to sprout and form new blood vessels in a controlled environment.

What are the implications of this study for therapy?

The findings may inform therapeutic strategies targeting neovascularization in hemangioblastomas.

Can this method be applied to other tumors?

Yes, the spheroid sprouting assay can be applied to study angiogenesis in various solid tumors.

What are the next steps in this research?

Future research will focus on further elucidating the mechanisms of neovascularization and potential therapeutic targets.

This paper presents a comprehensive procedure to evaluate in vitro whether classic tumor angiogenesis exists in hemangioblastomas (HBs) and its role in HBs. The results highlight the complexity of HB-neovascularization and suggest that this common form of angiogenesis is only a complementary mechanism in the HB-neovascularization.

The overall goal of this experiment is to evaluate the performance of the putative hemangioblastoma neovascularization using the spheroid sprouting assay in vitro. The method can help answer the key questions in the angiogenic field, such as tumor angiogenesis. The main advantage of this technique is that the product of a comprehensive procedure to evaluate in vitro where the classic tumor angiogenesis exists in hemangioblastoma and it grows in hemangioblastoma.

The implication of this technique extends toward therapy of hemangioblastumor and vasculaturement because the result highlight the complexity of hemangioblastumor neovascularization, and that suggests that this common form of angiogenesis is only a complementary mechanism. So this method can provide insight into the study of hemangioblastumor neovascularization. It can also be applied to tumors, angiogenesis, and vasculogenesis related application in some solid tumor, such as tumor vasculogenic mimicry in glass tumor.

View the full transcript and gain access to thousands of scientific videos